Streamline Pe Ratio vs Net Income Analysis
STRM Stock | USD 0.29 0.01 3.33% |
Streamline Health financial indicator trend analysis is much more than just breaking down Streamline Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Streamline Health is a good investment. Please check the relationship between Streamline Health Pe Ratio and its Net Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Pe Ratio vs Net Income
Pe Ratio vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Streamline Health Pe Ratio account and Net Income. At this time, the significance of the direction appears to have very week relationship.
The correlation between Streamline Health's Pe Ratio and Net Income is 0.25. Overlapping area represents the amount of variation of Pe Ratio that can explain the historical movement of Net Income in the same time period over historical financial statements of Streamline Health Solutions, assuming nothing else is changed. The correlation between historical values of Streamline Health's Pe Ratio and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pe Ratio of Streamline Health Solutions are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Pe Ratio i.e., Streamline Health's Pe Ratio and Net Income go up and down completely randomly.
Correlation Coefficient | 0.25 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Pe Ratio
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Streamline Health financial statement analysis. It represents the amount of money remaining after all of Streamline Health Solutions operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from Streamline Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Streamline Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Streamline Health's Tax Provision is very stable compared to the past year. As of the 4th of May 2024, Sales General And Administrative To Revenue is likely to grow to 0.47, while Discontinued Operations is likely to drop about 320.6 K.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 17.4M | 24.9M | 22.6M | 19.1M | Depreciation And Amortization | 5.1M | 4.5M | 4.2M | 2.9M |
Streamline Health fundamental ratios Correlations
Click cells to compare fundamentals
Streamline Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Streamline Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Short Long Term Debt Total | 3.8M | 2.7M | 10.1M | 9.7M | 10.6M | 6.0M | |
Other Current Liab | 2.5M | 1.5M | 6.5M | 7.0M | 3.8M | 2.8M | |
Total Current Liabilities | 15.6M | 7.4M | 13.5M | 16.8M | 13.7M | 10.2M | |
Total Stockholder Equity | 16.0M | 17.5M | 34.0M | 35.5M | 18.8M | 15.7M | |
Property Plant And Equipment Net | 152K | 495K | 341K | 111K | 88K | 83.6K | |
Net Debt | 2.2M | 312K | 256K | 3.2M | 7.4M | 7.7M | |
Retained Earnings | (79.4M) | (79.1M) | (85.7M) | (97.0M) | (115.7M) | (109.9M) | |
Accounts Payable | 1.3M | 272K | 778K | 626K | 1.3M | 1.1M | |
Non Current Assets Total | 25.1M | 18.7M | 46.7M | 45.5M | 32.9M | 19.3M | |
Non Currrent Assets Other | 695K | 886K | 948K | 1.7M | 1.7M | 1.2M | |
Net Receivables | 4.0M | 3.1M | 4.7M | 8.7M | 5.0M | 5.1M | |
Common Stock Shares Outstanding | 22.7M | 30.2M | 42.8M | 49.3M | 56.5M | 59.3M | |
Liabilities And Stockholders Equity | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Non Current Liabilities Total | 55K | 1.1M | 14.3M | 9.2M | 9.2M | 6.8M | |
Other Current Assets | 919K | 416K | 568K | 710K | 629K | 1.2M | |
Other Stockholder Equity | 95.1M | 96.3M | 119.2M | 132.0M | 133.9M | 140.6M | |
Total Liab | 15.6M | 8.5M | 27.8M | 26.0M | 22.9M | 16.6M | |
Total Current Assets | 6.6M | 7.3M | 15.1M | 16.0M | 8.8M | 12.7M | |
Short Term Debt | 3.8M | 1.7M | 454K | 785K | 1.5M | 1.2M | |
Cash | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Cash And Short Term Investments | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Property Plant And Equipment Gross | 152K | 495K | 341K | 357K | 321.3K | 305.2K | |
Other Liab | 55K | 130K | 4.6M | 271K | 311.7K | 296.1K | |
Other Assets | 695K | 886K | 948K | 1.7M | 1.5M | 1.0M | |
Common Stock Total Equity | 208K | 305K | 316K | 576K | 662.4K | 695.5K | |
Common Stock | 305K | 316K | 478K | 576K | 590K | 619.5K | |
Property Plant Equipment | 152K | 104K | 341K | 5.9M | 6.8M | 7.2M | |
Current Deferred Revenue | 8.0M | 3.9M | 5.8M | 8.4M | 7.1M | 6.8M | |
Intangible Assets | 8.7M | 6.6M | 22.3M | 20.6M | 17.9M | 13.0M | |
Inventory | 1.3M | 901K | 1.4M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | (8.2M) | 208K | (11.4M) | (2.4M) | (2.7M) | (2.9M) | |
Retained Earnings Total Equity | (76.6M) | (79.4M) | (79.1M) | (97.0M) | (87.3M) | (91.7M) | |
Long Term Debt Total | 3.9M | 3.4M | 989K | 9.0M | 8.1M | 5.4M | |
Capital Surpluse | 82.5M | 95.1M | 96.3M | 132.0M | 151.8M | 89.1M | |
Deferred Long Term Liab | 55K | 130K | 806K | 167K | 150.3K | 142.8K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Streamline Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Streamline Health's short interest history, or implied volatility extrapolated from Streamline Health options trading.
Currently Active Assets on Macroaxis
LAAC | Lithium Americas Corp | |
F | Ford Motor | |
CHPT | ChargePoint Holdings | |
AXL | American Axle Manufacturing | |
ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.33) | Revenue Per Share 0.4 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.